| Baseline sample before treatment (%) | First sample after treatment start (%) |  |
---|---|---|---|
Number of patients with Ki67 + ve CTC (%) | 23/51 (45.1) | 15/39 (38.5) | p = 0.528 |
Number of patients with ≥5 Ki67 + ve CTC (%) | 12/51 (23.5) | 6/39 (15.4) | p = 0.336 |
Number of patients with Vim + ve CTC (%) | 30/93 (32.3) | 19/49 (38.8) | p = 0.437 |
Number of patients with ≥5 Vim + ve CTC (%) | 10/93 (10.8) | 7/49 (14.3) | p = 0.558 |